Resources

Sanofi’s highly anticipated diet drug Acomplia (rimonabant) may also be useful in helping obese diabetics control their blood sugar levels, but some respected researchers have expressed skepticism and called for additional testing in the prestigious British medical journal Lancet.

Delaying diabetes until old age reduces late-life complications

Carrying two copies of a common variant of a particular gene doubles your chances of developing diabetes and puts you in a similar risk category to being clinically obese, according to a collaborative study led by UCL (University College London) researchers.

Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY)

According to one study it does not. But the study was flawed in that they did not educate the patient as what to do with the information.

People who regularly drink coffee may face a lower risk of developing diabetes than those who do not, says a new study.

Having a diabetes educator in your office practice can have dramatic results in improving diabetes control.

Results of a Phase 2 study show a 8% reduction in weight. Pramlintide shows weight loss for those even without diabetes.

Total all-cause annual treatment costs reduced by $1590 per patient.

New lipid targets of 78mg/dl (2.0 mmol/L)set out by the Canadian Diabetes Association (CDA) reflect more recent evidence from clinical trials and will affect the rates of cardiovascular disease in diabetic patients